In vitro molecular characterization of the development of the K65R and M184V mutations in subtype CHIV-1

被引：0
|
作者：
Coutsinos, D. [1 ]
Invernizzi, C. F. [1 ]
Xu, H. [1 ]
Brenner, B. G. [1 ]
Wainberg, M. A. [1 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3A 2T5, Canada
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [1] In vitro molecular characterization of the development of the K65R and M184V mutations in subtype C HIV-1
    Coutsinos, D.
    Invernizzi, C. F.
    Xu, H.
    Brenner, B. G.
    Wainberg, M. A.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S127 - S127
  • [2] Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
    Xu, Hong-Tao
    Martinez-Cajas, Jorge L.
    Ntemgwa, Michel L.
    Coutsinos, Dimitrios
    Frankel, Fernando A.
    Brenner, Bluma G.
    Wainberg, Mark A.
    RETROVIROLOGY, 2009, 6
  • [3] Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
    Hong-Tao Xu
    Jorge L Martinez-Cajas
    Michel L Ntemgwa
    Dimitrios Coutsinos
    Fernando A Frankel
    Bluma G Brenner
    Mark A Wainberg
    Retrovirology, 6
  • [4] Facilitated selection of K65R resistance with tenofovir pressure in subtype CHIV-1 isolates
    Brenner, B. G.
    Oliveira, M.
    Moisi, D.
    Doualla-Bell, F.
    Wainberg, M. A.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S166 - S166
  • [5] Dynamic of selection of the K65R and M184V/I mutations in patients enrolled in Tonus trial
    Delaunay, C
    Descamps, D
    Landman, R
    Peytavin, G
    Flandre, P
    Trylesinski, A
    Collin, G
    Benalycherif, A
    Monchecourt, F
    Brun-Vézinet, F
    ANTIVIRAL THERAPY, 2004, 9 (04) : U117 - U117
  • [6] Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations
    Frankel, Fernando A.
    Invernizzi, Cedric F.
    Oliveira, Maureen
    Wainberg, Mark A.
    AIDS, 2007, 21 (06) : 665 - 675
  • [7] Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations
    Oliveira, Maureen
    Moisi, Daniela
    Spira, Bonnie
    Cox, Susan
    Brenner, Bluma G.
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1683 - 1685
  • [8] Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
    Deval, J
    White, KL
    Miller, MD
    Parkin, NT
    Courcambeck, J
    Halfon, P
    Selmi, B
    Boretto, J
    Canard, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 509 - 516
  • [9] Sensitivity of phenotypic analyses for detection of K65R or M184V in mixtures with wild-type HIV-1
    Underwood, MR
    Ross, LL
    Irlbeck, DM
    Gerondelis, P
    StClair, MH
    Trinh, L
    Parkin, N
    Lanier, ER
    ANTIVIRAL THERAPY, 2004, 9 (04) : U101 - U101
  • [10] K65R development among subtype CHIV-1-infected patients in tenofovir DF clinical trials
    Miller, Michael D.
    Margot, Nicolas
    McColl, Damian
    Cheng, Andrew K.
    AIDS, 2007, 21 (02) : 265 - 266
12345